子宫肌瘤治疗对生活质量和心理健康的影响:一项系统综述
该系统综述检索1990年1月至2023年10月五个数据库,纳入67项研究(18项随机对照试验和49项观察性研究),评估影像学、药物或手术干预前后子宫肌瘤对生活质量量表的影响。所有干预均与肌瘤特异性生活质量、心理健康指标显著改善及症状严重程度评分降低相关。
要点
- 所有干预均与肌瘤特异性生活质量及心理健康指标显著改善相关。
- 所有干预均与症状严重程度评分降低相关。
- 共纳入67项研究,含18项随机对照试验和49项观察性研究。
核心结论
- 数据表明子宫肌瘤对患者生活质量和心理健康有实质性影响,并提示可用于比较不同肌瘤治疗方案的指标。
研究设计与样本
- 系统综述,检索PubMed、PsycINFO、ClinicalTrials.gov、Embase和Cochrane Library 1990年1月至2023年10月的文献。
- 纳入经影像学确认的有症状子宫肌瘤的绝经前女性,接受针对肌瘤的影像学、药物或手术干预或联合干预。
- 仅纳入使用经验证问卷且有治疗前基线及治疗后评分的报告。
- 排除围绝经期或绝经后患者、合并有相似症状的其他疾病者、未聚焦生活质量评估的研究。
- 最终纳入67项研究:18项随机对照试验和49项观察性研究;偏倚风险采用Cochrane RoB 2.0或Newcastle-Ottawa量表评估。
主要发现
- 所有干预均与子宫肌瘤特异性生活质量指标显著改善相关。
- 所有干预均与心理健康指标显著改善相关。
- 所有干预均与症状严重程度评分降低相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fibroids significantly impact the quality of life (QOL) and mental health of affected women. However, there are limited comparative data on QOL measures after medical, surgical, and radiologic interventions in women with fibroids. This study aimed to assess the current literature evaluating the impact of fibroids on QOL measures using several validated questionnaires for radiologic, medical, or surgical interventions or a combination of interventions before and after treatment. PubMed, PsycINFO, ClinicalTrials.gov, Embase, and Cochrane Library were searched from January 1990 to October 2023 to evaluate the available evidence, and the risk of bias was assessed using Cochrane RoB 2.0 or the Newcastle-Ottawa Scale. The review criteria included randomized controlled trials (RCTs) and observational cohort studies that included premenopausal women with symptomatic uterine fibroids, confirmed by imaging, who underwent an intervention to target fibroid disease. Only reports using validated questionnaires with a numerical baseline (pretreatment) and posttreatment scores were included. The exclusion criteria included perimenopausal or postmenopausal patients, conditions in addition to uterine fibroids that share similar symptoms, or studies that did not focus on QOL assessment. Abstracts were screened, and full texts were reviewed to determine whether studies met the inclusion criteria. A total of 67 studies were included after final review: 18 RCTs and 49 observational studies. All interventions were associated with a significant improvement in uterine fibroid-specific QOL measures, mental health metrics, and a reduction in symptom severity scores after treatment. These data reveal a substantial impact of uterine fibroids on the QOL and mental health of women with fibroids and indicate the metrics that can be used to compare the effectiveness of fibroid treatment options.
引用
- Neumann B, Singh B, Brennan J, et al. The impact of fibroid treatments on quality of life and mental health: a systematic review. Fertil Steril. 2024. PMID: 38246400. doi:10.1016/j.fertnstert.2024.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。